Number of the records: 1  

INFRAFRONTIER quality principles in systemic phenotyping

  1. SYS0554550
    LBL
      
    01000a^^22220027750^450
    005
      
    20240103230510.7
    014
      
    $a 34328547 $2 PUBMED
    014
      
    $a 000679610900001 $2 WOS
    017
    70
    $a 10.1007/s00335-021-09892-2 $2 DOI
    100
      
    $a 20220228d m y slo 03 ba
    101
    0-
    $a eng
    102
      
    $a US
    200
    1-
    $a INFRAFRONTIER quality principles in systemic phenotyping
    215
      
    $a 3 s. $c E
    300
      
    $a změna roku vydání - smazáno z RIV, posláno v roce 2023 znovu
    463
    -1
    $1 001 cav_un_epca*0257212 $1 011 $a 0938-8990 $e 1432-1777 $1 200 1 $a Mammalian Genome $v Roč. 33, č. 1 (2022), s. 120-122 $1 210 $c Springer
    608
      
    $a Article
    608
      
    $a Early Access
    610
      
    $a quality control
    610
      
    $a phenotyping
    610
      
    $a animal model
    610
      
    $a reproducibility
    610
      
    $a replicability
    610
      
    $a ethics
    700
    -1
    $3 cav_un_auth*0425704 $a Ehlich $b H. $y DE $4 070 $q INFRAFRONTIER GmbH, Neuherberg, Germany,
    701
    -1
    $3 cav_un_auth*0425705 $a Cater $b H. $y GB $4 070 $q Harwell Campus, Mary Lyon Ctr, MRC Harwell Inst, Didcot, Oxon, England,
    701
    -1
    $3 cav_un_auth*0393805 $a Flenniken $b A.M. $y CA $q Sinai Hlth, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada, Ctr Phenogen, Toronto, ON, Canada
    701
    -1
    $3 cav_un_auth*0425706 $a Goncalves Da Cruz $b I. $y FR $4 070 $q Univ Strasbourg, CNRS, INSERM, CELPHEDIA,PHENOMIN,Inst Clin La Souris, Illkirch Graffenstaden, France,
    701
    -1
    $3 cav_un_auth*0425707 $a Mura $b A. $y FR $4 070 $q Aix Marseille Univ, Ctr Immunophenom CIPHE, INSERM, CNRS,CELPHEDIA,PHENOMIN, Marseille, France,
    701
    -1
    $3 cav_un_auth*0425708 $a Ntafis $b V. $y GR $4 070 $q Biomed Sci Res Ctr Alexander Fleming, Athens, Greece,
    701
    -1
    $3 cav_un_auth*0425709 $a Raess $b M. $y DE $4 070 $q INFRAFRONTIER GmbH, Neuherberg, Germany,
    701
    -1
    $3 cav_un_auth*0425710 $a Selloum $b M. $y FR $4 070 $q Univ Strasbourg, CNRS, INSERM, CELPHEDIA,PHENOMIN,Inst Clin La Souris, Illkirch Graffenstaden, France,
    701
    -1
    $3 cav_un_auth*0425711 $a Stoeger $b C. $y DE $4 070 $q Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, Neuherberg, Germany,
    701
    -1
    $3 cav_un_auth*0278323 $a Suchanová $b Šárka $p UMG-J $i Oddělení transgenních modelů nemocí $j Laboratory of Transgenic Models of Diseases $k 18 $l 18 $T Ústav molekulární genetiky AV ČR, v. v. i.
    701
    -1
    $3 cav_un_auth*0403371 $a Vuolteenaho $b R. $y FI $q Univ Oulu, Bioctr Oulu, Transgen & Tissue Phenotyping Core Facil, Oulu, Finland,
    701
    -1
    $3 cav_un_auth*0393810 $a Brown s $b S.D.M. $y GB $q Harwell Campus, Mammalian Genet Unit, Med Res Council, MRC Harwell Inst, Didcot, Oxon, England,
    701
    -1
    $3 cav_un_auth*0375689 $a Herault $b Y. $y FR $q Univ Strasbourg, CNRS, INSERM, CELPHEDIA,PHENOMIN,Inst Clin La Souris, Illkirch Graffenstaden, France,
    701
    -1
    $3 cav_un_auth*0425712 $a Hinttala $b R. $y FI $4 070 $q Univ Oulu, Bioctr Oulu, Transgen & Tissue Phenotyping Core Facil, Oulu, Finland, Univ Oulu, Oulu, Finland, Oulu Univ Hosp, PEDEGO Res Unit, Oulu, Finland, Med Res Ctr Oulu, Oulu, Finland
    701
    -1
    $3 cav_un_auth*0425713 $a Hrabe de Angelis $b M. $y DE $4 070 $q INFRAFRONTIER GmbH, Neuherberg, Germany, Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, Neuherberg, Germany, German Ctr Diabet Res DZD, Neuherberg, Germany, Tech Univ Munich, TUM Sch Life Sci, Chair Expt Genet, Freising Weihenstephan, Germany
    701
    -1
    $3 cav_un_auth*0022708 $a Kollias $b G. $y GR $q Biomed Sci Res Ctr Alexander Fleming, Athens, Greece,
    701
    -1
    $3 cav_un_auth*0425714 $a Kontoyiannis $b D.L. $y GR $4 070 $q Biomed Sci Res Ctr Alexander Fleming, Athens, Greece,
    701
    -1
    $3 cav_un_auth*0044912 $a Malissen $b B. $y FR $4 070 $q Aix Marseille Univ, Ctr Immunophenom CIPHE, INSERM, CNRS,CELPHEDIA,PHENOMIN, Marseille, France,
    701
    -1
    $3 cav_un_auth*0287283 $a McKerlie $b C. $y CA $q Hosp Sick Children, Toronto, ON, Canada, Univ Toronto, Fac Med, Toronto, ON, Canada
    701
    -1
    $3 cav_un_auth*0241788 $a Sedláček $b Radislav $p UMG-J $i Oddělení transgenních modelů nemocí $j Laboratory of Transgenic Models of Diseases $k 18 $l 18 $T Ústav molekulární genetiky AV ČR, v. v. i.
    701
    -1
    $3 cav_un_auth*0425370 $a Wells $b S. $y GB $q Harwell Campus, Mary Lyon Ctr, MRC Harwell Inst, Didcot, Oxon, England,
    701
    -1
    $3 cav_un_auth*0425715 $a Zarubica $b A. $y FR $4 070 $q Aix Marseille Univ, Ctr Immunophenom CIPHE, INSERM, CNRS,CELPHEDIA,PHENOMIN, Marseille, France,
    701
    -1
    $3 cav_un_auth*0393817 $a Rozman $b Jan $p UMG-J $i Oddělení transgenních modelů nemocí $j Laboratory of Transgenic Models of Diseases $k 18 $l 18 $y DE $A 0000-0002-8035-8904 $B A-2540-2010 $T Ústav molekulární genetiky AV ČR, v. v. i.
    701
    -1
    $3 cav_un_auth*0393807 $a Sorg $b T. $y FR $4 070 $z K $q Univ Strasbourg, CNRS, INSERM, CELPHEDIA,PHENOMIN,Inst Clin La Souris, Illkirch Graffenstaden, France,
    856
      
    $u https://link.springer.com/article/10.1007/s00335-021-09892-2 $9 RIV
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.